Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hale

Showing results (61-70 of 354) with videos related to

Pageof 36
Sort By:
Oral and Maxillofacial Surgery Clinics of North America|October 23, 2008
Head and neck manifestations of tuberculosisRobert G Hale, David I Tucker
Bone Marrow Transplantation|May 1, 1988
Specificity of monoclonal antibody Campath-1G Hale, H Waldmann, M Dyer
Physical Therapy|January 1, 1978
A commentary on electromyographic feedback in physical therapyC Gonnella, R Kalish, G Hale
Clinical and Experimental Dermatology|July 26, 2021
Incomplete excision of basal cell carcinoma: combining multidisciplinary data gives a better overall understanding of riskG Hale, M Wiener, P Athavale
Advances in Experimental Medicine and Biology|January 1, 1985
Interaction of rat monoclonal antibodies with human killer cellsM Clark, G Hale, H Waldmann
Perception|November 2, 2023
Exploring watercolor illusion spreading between dissected stimulus partsRalph G Hale, James M Brown
Pharmacology|January 1, 1992
The interconversion of prednisone and prednisolone in human and rabbit organs in vitro is a function of tissue integrityV G Hale, L Z Benet
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 26, 2001
Appropriate targets for monoclonal antibodies in the induction of transplantation toleranceH Waldmann, G Hale, S Cobbold
Transplantation Proceedings|July 15, 2004
Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here?S Chakrabarti, G Hale, H Waldmann
Lancet (London, England)|January 3, 1987
Leukaemic relapse after Campath 1-treated bone-marrow transplantation for leukaemiaH Waldmann, S Cobbold, G Hale
Pageof 36

Showing results (61-70 of 354) with videos related to

Sort By:
Pageof 36
Oral and Maxillofacial Surgery Clinics of North America|October 23, 2008
Head and neck manifestations of tuberculosisRobert G Hale, David I Tucker
Bone Marrow Transplantation|May 1, 1988
Specificity of monoclonal antibody Campath-1G Hale, H Waldmann, M Dyer
Physical Therapy|January 1, 1978
A commentary on electromyographic feedback in physical therapyC Gonnella, R Kalish, G Hale
Clinical and Experimental Dermatology|July 26, 2021
Incomplete excision of basal cell carcinoma: combining multidisciplinary data gives a better overall understanding of riskG Hale, M Wiener, P Athavale
Advances in Experimental Medicine and Biology|January 1, 1985
Interaction of rat monoclonal antibodies with human killer cellsM Clark, G Hale, H Waldmann
Perception|November 2, 2023
Exploring watercolor illusion spreading between dissected stimulus partsRalph G Hale, James M Brown
Pharmacology|January 1, 1992
The interconversion of prednisone and prednisolone in human and rabbit organs in vitro is a function of tissue integrityV G Hale, L Z Benet
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|May 26, 2001
Appropriate targets for monoclonal antibodies in the induction of transplantation toleranceH Waldmann, G Hale, S Cobbold
Transplantation Proceedings|July 15, 2004
Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: where do we go from here?S Chakrabarti, G Hale, H Waldmann
Lancet (London, England)|January 3, 1987
Leukaemic relapse after Campath 1-treated bone-marrow transplantation for leukaemiaH Waldmann, S Cobbold, G Hale
Pageof 36